Androgenetic alopecia: an evidence-based treatment update
- PMID: 24848508
- DOI: 10.1007/s40257-014-0077-5
Androgenetic alopecia: an evidence-based treatment update
Abstract
Background: Androgenetic alopecia (AGA) is one of the most common chronic problems seen by dermatologists worldwide. It is characterized by progressive hair loss, especially of scalp hair, and has distinctive patterns of loss in women versus men, but in both genders the central scalp is most severely affected. It often begins around puberty and is known to effect self-esteem and the individual's quality of life. In contrast to the high prevalence of AGA, approved therapeutic options are limited. In addition to the scarce pharmacologic treatments, there are numerous nonprescription products claimed to be effective in restoring hair in androgenetic alopecia.
Objectives: The purpose of this paper is to review published medical and non-medical treatments for male and female AGA using the American College of Physicians evidence assessment methods. MEDLINE, EMBASE and Cochrane Library were searched for systematic reviews, randomized controlled trials, open studies, case reports and relevant studies of the treatment of male and female AGA. The relevant articles were classified according to grade and level of evidence.
Results: The medical treatments with the best level of evidence classification for efficacy and safety for male AGA are oral finasteride and topical minoxidil solution. For female AGA, topical minoxidil solution appears to be the most effective and safe treatment. The medical treatments corresponding to the next level of evidence quality are some commonly used therapeutic non-FDA-approved options including oral and topical anti-hormonal treatments. Surgical treatment of follicular unit hair transplantation is an option in cases that have failed medical treatment although there is high variation in outcomes.
Limitations: Some articles, especially those concerning traditional herbs claimed to promote hair regrowth, were published in non-English, local journals.
Conclusions: An assessment of the evidence quality of current publications indicates that oral finasteride (for men only) and topical minoxidil (for men and women) are the best treatments of AGA.
Similar articles
-
Multi-therapies in androgenetic alopecia: review and clinical experiences.Dermatol Ther. 2016 Nov;29(6):424-432. doi: 10.1111/dth.12390. Epub 2016 Jul 18. Dermatol Ther. 2016. PMID: 27424565 Review.
-
A review of the treatment of male pattern hair loss.Expert Opin Pharmacother. 2020 Apr;21(5):603-612. doi: 10.1080/14656566.2020.1721463. Epub 2020 Feb 17. Expert Opin Pharmacother. 2020. PMID: 32066284 Review.
-
An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.Dermatology. 2004;209(2):117-25. doi: 10.1159/000079595. Dermatology. 2004. PMID: 15316165 Clinical Trial.
-
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.J Am Acad Dermatol. 2017 Jul;77(1):136-141.e5. doi: 10.1016/j.jaad.2017.02.054. Epub 2017 Apr 7. J Am Acad Dermatol. 2017. PMID: 28396101 Review.
-
Controversies in the treatment of androgenetic alopecia: The history of finasteride.Dermatol Ther. 2019 Mar;32(2):e12647. doi: 10.1111/dth.12647. Epub 2018 Sep 25. Dermatol Ther. 2019. PMID: 30253001
Cited by
-
Growth Factor Cocktail Including Fibroblast Growth Factor 9 (Cellcurin) in the Treatment of Androgenetic Alopecia in Men and Women: A Randomized Controlled Trial.Int J Trichology. 2023 Jul-Aug;15(4):133-143. doi: 10.4103/ijt.ijt_39_21. Epub 2024 Apr 5. Int J Trichology. 2023. PMID: 38765719 Free PMC article.
-
The psychosocial burden of androgenetic alopecia in Saudi Arabia: A cross-sectional study.J Family Med Prim Care. 2023 Dec;12(12):3374-3379. doi: 10.4103/jfmpc.jfmpc_1151_23. Epub 2023 Dec 21. J Family Med Prim Care. 2023. PMID: 38361837 Free PMC article.
-
Minoxidil delivered via a stem cell membrane delivery controlled release system promotes hair growth in C57BL/6J mice.Front Bioeng Biotechnol. 2024 Jan 8;11:1331754. doi: 10.3389/fbioe.2023.1331754. eCollection 2023. Front Bioeng Biotechnol. 2024. PMID: 38260729 Free PMC article.
-
Deciphering the molecular mechanisms of stem cell dynamics in hair follicle regeneration.Exp Mol Med. 2024 Feb;56(1):110-117. doi: 10.1038/s12276-023-01151-5. Epub 2024 Jan 5. Exp Mol Med. 2024. PMID: 38182654 Free PMC article. Review.
-
Analysis of 72,469 UK Biobank exomes links rare variants to male-pattern hair loss.Nat Commun. 2023 Sep 22;14(1):5492. doi: 10.1038/s41467-023-41186-w. Nat Commun. 2023. PMID: 37737258 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous